TABLE 1.
Demographic and clinical characteristics of included Parkinson’s disease (PD) subjects.
| n = 87 | |
| Age | 67.9 (7.6) |
| Gender (m:f) | 67:20 |
| Education (years) | 15.6 (2.7) |
| Motor disease duration (years) | 5.8 (4.6) |
| Hoehn and Yahr stage | 2.4 (0.6) |
| MDS-UPDRS-III | 34.3 (12.1) |
| LED (mg) | 639.7 (413) |
| Cognitive status (PD-NC:PD-MCI) | 48:39 |
| Z-score memory | −0.44 (1.03) |
| Z-score attention | −0.41 (0.87) |
| Z-score executive function | −0.55 (1.27) |
| Z-score language | −0.48 (1.11) |
| Z-score visuospatial function | −0.12 (0.84) |
Mean and SD are presented for numerical variables. MDS-UPDRS, Movement Disorders Society-revised Unified Parkinson’s Disease Rating Scale; LED, Levodopa Equivalent Dose; PD-NC, Parkinson’s disease normal cognition; PD-MCI, Parkinson’s disease with mild cognitive impairment.